I-ACT: Phase I trial of Amnion Cell Therapy for Ischaemic Stroke to establish the maximum tolerable dose

  • Phan, Thanh (Primary Chief Investigator (PCI))
  • Ma, Henry (Chief Investigator (CI))
  • Lim, Rebecca (Chief Investigator (CI))
  • Sobey, Christopher (Chief Investigator (CI))

Project: Research

Short titlePhase I trial of Amnion Cell Therapy for Ischaemic Stroke
AcronymI-ACT
StatusActive
Effective start/end date1/01/1931/12/21

Funding

  • National Health & Medical Research Council (NHMRC): AUD711,031.90